Estrogen: A Novel Therapeutic Adjunct for the Treatment of Trauma-Hemorrhage–Induced Immunological Alterations

Abstract

Trauma-hemorrhage leads to prolonged immune suppression, sepsis, and multiple organ failure. The condition affects all compartments of the immune system, and extensive studies have been carried out elucidating the immunological events following trauma-hemorrhage. The immune alteration observed following trauma-hemorrhage is gender dependent in both animal models and humans, though some studies in humans are contradictory. Within 30 min after trauma-hemorrhage, splenic and peritoneal macrophages, as well as T-cell function, are depressed in male animals, but not in proestrus females. Studies have also shown that the survival rate and the induction of subsequent sepsis following trauma-hemorrhage are significantly higher in males and ovariectomized females compared with proestrus females. These and other investigations show that sex hormones form the basis of this gender dichotomy, and administration of estrogen can ameliorate the immune depression and increase the survival rate after trauma-hemorrhage. This review specifically elaborates the studies carried out thus far demonstrating immunological alteration after trauma-hemorrhage and its modulation by estrogen. Also, estrogen was shown to produce its salutary effects through nuclear as well as extranuclear receptors. Estrogen rapidly activates several protein kinases and phosphatases, as well as the release of calcium in different cell types. The results of the studies exemplify the promise of estrogen as a therapeutic adjunct in treating adverse pathophysiological conditions following trauma-hemorrhage.

INTRODUCTION

The increased longevity of women (1) and their resilience to septic complications following injury are well described in the literature. The protection from complications and mortality associated with injury, trauma, and sepsis in females (2–5) is mostly attributed to the female sex hormone, estrogen (E2). On the contrary, women are more susceptible to several autoimmune diseases compared with men (6). It is suggested that increased propensity to inflammatory diseases, such as rheumatoid arthritis in women, is due to a more active immune system than in men—who are more prone to infections following injury (6). This is supported by observations such as the following: female mice produce more antibody and stronger T-cell response than males in response to immunizations (7,8); females mount stronger humoral immune responses to vaccines and reject allograft more rapidly than males (9,10); and there are significantly higher numbers of CD4⁺ T cells in females (11). Several studies demonstrate a naturally occurring sex difference in immune responses which persists after traumatic injury (4,12). Male sex and age are reported to be risk factors for development of sepsis and multiple organ failure after trauma (13–19). E2 plays a significant role in the sex dichotomy seen in response to injury or onset of autoimmune disease. In 1898, Calzolari observed an enlargement of the thymus when rabbits were castrated before sexual maturity, and documented a relationship between sexual environment and immunity (20). Exogenous E2 replacement in animals and humans promoted wound healing, and hormone replacement therapy in postmenopausal women was reported to prevent the development of chronic wounds (21–23). Also, E2 supplementation has been shown to reduce or reverse trauma-hemorrhagic shock–induced organ dysfunction in animal models (4,12).

ESTROGEN, MECHANISM OF ACTION

E2, the female hormone, is mainly produced by the ovaries and the placenta. The three major estrogens in women are estradiol, estriol, and estrone (Figure 1). Estrogens are synthesized from androgens by the loss of C-19 angular methyl group and the formation of an aromatic A ring. Whereas estradiol is derived from testosterone, estrone is derived from androstenedione. The main form of E2 in women before menopause is estradiol. E2 mainly mediates its action through its intracellular receptors, called E2 receptors (ER). ER-α and ER-β are the two major forms of ER, belonging to a large family of transcription factors, the nuclear receptor family, and are located mostly in the intracellular compartment. Several isoforms exist within each ER subtype and are present in almost all cells, though each cell may have a predominant subtype expression. E2 binding leads to activation and dimerization of ER followed by translocation into the nucleus, where it binds to specific DNA segments of the estrogen-responsive genes. The metabolic and physiologic effects of E2 were previously known to be mediated by nuclear E2 receptors. Further, there is evidence indicating that mitochondria-localized ERs alter mitochondrial gene expression (24).

Figure 1.

Structure of estrogens: estradiol, estrone, and estriol.

Apart from the genomic actions of E2, nongenomic actions (also termed extranuclear functions) are also described (25). A cell surface receptor, G-protein coupled receptor (GPR) 30, is described to have affinity to E2 (26–30) (Figure 2). Studies have shown that GPR30 over-expression in breast cancer cells deficient in ER-α and ER-β restores the activation of adenyl cyclase by E2. Additionally, silencing of GPR30 expression with small interfering RNA (siRNA) prevents E2-mediated cAMP-dependent signaling in keratinocytes and in SKBR3 breast cancer cells that lack ER-α and ER-β (29). The GPR30-mediated effect is distinct from the ER-mediated salutary effect of E2, and the former is also called a nongenomic effect (Figure 2). Nongenomic effects are usually measured as increase in phosphorylation of proteins, or increase in intracellular calcium (31). Compared with the conventional genomic effect, which constitutes intracellular binding of E2 to ER and gene activation, there is a more rapid (milliseconds to minutes) effect due to the nongenomic pathway which is initiated at the plasma membrane by E2 binding to GPR30 (28,30). Plasma membrane–associated ERs and their responsiveness to E2 have also been reported. They have been implicated in PI-3K/Akt activation and the rapid release of NO in endothelial cells (29,32). Therefore, the functional effect of estrogen is not necessarily mediated through processes that require gene transcription, but can also be immediate through its extranuclear effect by mobilizing key cytosolic enzymes (25,30).

Figure 2.

Genomic and nongenomic effects of estrogen. When estrogen (E2) binds estrogen receptors (ER) in the cytoplasm, they undergo homodimerization, translocation to the nucleus, and bind to estrogen responsive element (ERE) of genes and initiate specific gene transcriptions, acting like a transcription factor. Alternatively, the E2-bound GPR30 may initiate activation of protein kinases such as PKA, PKB, and PKC. This may be followed by the activation of intracellular E2-bound ER (30), other transcription factors such as cAMP response element–binding protein (CREB) or mobilization of intracellular calcium stores. The latter processes which are independent of ER, also known as nongenomic effect, facilitate a rapid response to stimuli. CREB binds to cAMP response element (CRE) to initiate transcription. A subset of ERs also associate with plasma membrane and interact with transmembrane growth factor receptors such as insulin-like growth factor receptor I, and epidermal growth factor receptor to induce nongenomic effects by protein–protein interactions (129). Recently it has been shown that PKA activation and Bcl-2 expression in the liver of E2-treated trauma-hemorrhage rats are initiated by E2 binding to GPR30 (130).

SEX DICHOTOMY IN TRAUMA OUTCOME

Multiple injuries and major hemorrhage induce marked dysregulation of the systemic immune response, end organ damage, and death (33–38). In patients with multiple injuries who are at risk for infectious complications, outcome is believed to be determined by the interrelationship of various inflammatory and anti-inflammatory factors after the trauma (36,39–47). Several studies have demonstrated that a profound deterioration of immune functions, characterized by a prolonged immune suppression, is initiated within the first hour of severe trauma or surgical procedures (14,17,42,48,49). The immunosuppression paves the way for secondary complications of sepsis and multiple organ failure. Following trauma-hemorrhagic shock, cardiovascular, hepatic, and immune functions are depressed in males as well as ovariectomized and aged females, but not in proestrus females, and remain depressed despite fluid resuscitation (17,50–54). However, administration of E2 was found to restore cardiovascular, hepatocellular, and immune functions following trauma-hemorrhage in male rodents (55,56).

In a study of 84 patients who sustained blunt injuries, a sex-specific regulation of leukocyte function was demonstrated in patients within the early posttraumatic period (39). In another study of 584 patients who underwent abdominal surgery, factors contributing to 30-day mortality in patients aged ≤50 years was found to differ between males and females (57). Studies show that more men died of myocardial infarction before reaching the hospital, though the 28-day mortality for men and women was the same (14,58). In a recent study of 5192 patients at a level I trauma center (59), Deitch et al. found that hormonally active women have a better physiologic response to similar degrees of shock and trauma than do their male counterparts. Though several clinical studies demonstrated the influence of sex in the outcome following trauma, several studies were unable to identify any such association (3,60–62). One of the reasons for contradictory or less convincing evidence for the influence of sex postinjury, and in sepsis in some studies in the human, may be heterogeneity of the population studied in relation to their hormonal status. The prevailing hormonal milieu at the time of injury, and not subsequently, appears to be of paramount importance, as this determines whether the patient will maintain immunocompetence and organ function or develop immunocompromise and organ dysfunction following injury. If such is the case, the lack of consideration of this parameter in clinical studies might contribute to confusing and unreliable results. However, a more pronounced and convincing sex-associated difference has been observed in animal studies under well-controlled conditions such as hormonal and nutritional status, preexisting conditions, and genetic homogeneity.

IMMUNE ALTERATIONS AFTER TRAUMA-HEMORRHAGE AND THE ROLE OF ESTROGENS

Both cardiovascular and immune functions are maintained in proestrus females following trauma-hemorrhage, but females in the other stages of the estrus cycle are not protected (17). In rodents, E2 levels are lowest during estrus and metestrus, gradually increasing during diestrus, and reaching a peak at proestrus stage (63). It has been demonstrated that female hormones, E2 and prolactin, modulate immune responsiveness in adult mice and that the proestrus state of the estrus cycle is characterized by a more vigorous immune response compared with the diestrus state (64–67). The observed restoration of organ function following trauma-hemorrhage after flutamide administration was also found to be estrogen-mediated, owing to increases in estrogen levels by increasing the conversion of testosterone to estrogen (68). Similarly, dehydroepiandrosterone (DHEA) also has protective effects following trauma-hemorrhage, which are mediated through estrogen receptors (69). Several studies in animal models show that E2 administration is beneficial in males as well as females in maintaining organ function following trauma-hemorrhage.

Prolonged immune suppression, initiated shortly after injury, persists despite fluid resuscitation. This is characterized by a decrease in T- and B-cell function, depressed splenic dendritic cell function, depressed macrophage antigen presentation function, and altered cytokine release (4,17,70,71). In a recent study, significant decreases in splenic dendritic cell antigen presentation capacity, MHC class II expression, LPS-induced IL-12 production, and LPS- or IL-12–induced IFN-γ production were observed after trauma-hemorrhage (70). This immunological alteration could contribute to the host’s enhanced susceptibility to sepsis following trauma-hemorrhage. Although antigen presentation function is depressed in all populations of macrophages, including splenic and peritoneal, after trauma-hemorrhage, Kupffer cell proinflammatory cytokine production is increased. The cytokine release capacity of splenic and peritoneal macrophages is also decreased. These events are reversed by estrogen administration. In addition to immune perturbations, cardiac functions are significantly depressed in male mice and rats after trauma hemorrhage, whereas they are maintained on estrogen supplementation or in proestrus females. The mRNA and protein expression of both ER-α and ER-β were found to be decreased in cardiomyocytes after trauma-hemorrhage, and flutamide was found to normalize the ER expression (72). Extensive studies, as reviewed below, have been conducted to address the impact of trauma-hemorrhage on individual immune compartments and the effect of estrogen administration (Table 1).

Table 1.

Immunological alterations after trauma-hemorrhage and effect of estrogen in restoring the altered functions.

Immune compartment	Function	Trauma-hemorrhage	Estrogen administration
Neutrophils	KC production	↑	→
	Tissue infiltration	↑	→
Macrophages (PBMC, spleen, peritoneal cavity)	Antigen presentation	↓	→
	IL-Iβ, IL-6, and TNF-α production	↓	→
Dendritic cells (spleen)	Maturation	↓	→
	Antigen presentation	↓
	IL-6, and TNF-α production	↓
Kupffer cells
	Antigen presentation	↓	→
	IL-6 and TNF-α production	↑	→
T cells
	T-cell proliferation	↓	→
	T-cell function	↓	→
	Apoptosis	↑	ND

↑ , enhanced/upregulated; ↓, decreased/downregulated; →, restored.

Neutrophils

Neutrophils play an important role in inflammation in the liver, small intestine, and lung in low-flow states (73,74). The proinflammatory milieu following trauma-hemorrhage recruits neutrophils into tissues, thereby increasing leukocyte trafficking and tissue permeability (75–77). Neutrophils can release superoxide anions and proteolytic enzymes, which diffuse across the endothelium and injure parenchymal cells. Alternatively, neutrophils can leave the microcirculation, and migrate and adhere to matrix proteins or other cells (78). After trauma-hemorrhagic shock, inflammatory products exit the gut via mesenteric lymph, prime neutrophils, and predispose to lung injury. It has been observed that plasma from male rats subjected to trauma-hemorrhage primes neutrophil respiratory burst, but plasma from proestrus females subjected to trauma-hemorrhage does not (79). Intraluminal nafamostat (serine protease inhibitor) reduced trauma-hemorrhage–induced gut and lung injury as well as neutrophil-activating ability, demonstrating that neutrophil-derived serine proteases play an important role in trauma-hemorrhage–induced gut and lung injury (80). Ischemic gut is a major source of factors that lead to neutrophil activation (81). A striking sexual dimorphism in neutrophil activation was also observed after trauma-hemorrhage, as estrogen limited trauma-induced neutrophil activation whereas testosterone potentiated it (82). It has also been shown that keratinocyte-derived chemokine (KC), a chemoattractant for neutrophils, is up-regulated after trauma-hemorrhage, and KC was found to play a critical role in the induction of systemic inflammation and tissue damage after trauma-hemorrhage (83). This was further substantiated by studies which showed that administration of the anti-KC antibody before trauma-hemorrhage prevented increases in KC plasma levels, which was accompanied by amelioration of neutrophil infiltration and edema formation in lung and liver after trauma-hemorrhage (83). E2 prevents end organ infiltration of neutrophils, and this is possibly mediated through the demonstrated inhibitory effect of E2 on KC (84). Further, mice with functional TLR4 expression showed elevated lung neutrophil infiltration following trauma-hemorrhage, which was not observed in TLR4 mutant mice, suggesting the role of neutrophils in mediating the inflammatory response following trauma-hemorrhage (85). It was also found that E2 administration after trauma-hemorrhage reduces tissue neutrophil sequestration in male rodents, and the salutary effects of E2 administration on tissue neutrophil sequestration following the trauma are receptor subtype- and tissue-specific (74).

Macrophages and Dendritic Cells

The depression of immune response normally observed in male animals following trauma-hemorrhage can also be prevented by precastration or administration of flutamide, an androgen receptor antagonist (86–88). In addition, the administration of 5α-dihydrotestosterone (DHT) to female mice depressed the splenic and peritoneal macrophage immune response after trauma-hemorrhage to levels comparable to those seen in males under such conditions (89,90). Similarly, a significant decrease in the release of the proinflammatory cytokines IL-1β and IL-6 by splenic macrophages and peritoneal macrophages was observed in DHT-treated castrated male mice following trauma-hemorrhage (91). MHC class II expression was also shown to be decreased in peritoneal and splenic macrophages after trauma-hemorrhage (92). Estrogens have been shown to increase the resistance of host animals to infections and also stimulate macrophage functions, suggesting that female sex steroids should improve macrophage function in contrast to the immunodepressive effects of male sex steroids (93–95). The administration of ER-α agonist propyl pyrazole triol (PPT), but not ER-β agonist diarylpropionitrile (DPN), following trauma-hemorrhage was as effective as E2 in preventing the suppression in splenic macrophage cytokine production (96). Therefore, it appears that ER-α plays the predominant role in mediating the salutary effects of E2 on splenic macrophage cytokine production following trauma-hemorrhage and that such effects are likely mediated via normalization of MAPK, but not NF-κB signaling pathways (96). When trauma-hemorrhage animals were treated with a cell-impermeable E2 conjugated with BSA (E2-BSA) to study the effect on splenic macrophages, E2-BSA was found to be equally effective as E2, demonstrating nongenomic effects of E2 (97) (Figure 2).

Dendritic cells are known to be professional antigen-presenting cells. When the role of dendritic cells in depressed immune function after trauma-hemorrhage was investigated, it was observed that splenic dendritic cell antigen presentation capacity, MHC class II expression, and cytokine production (IL-12 and IFN-γ) were significantly decreased following trauma-hemorrhage (70). This depression in antigen presentation could contribute to the host’s enhanced susceptibility to sepsis following trauma-hemorrhage (70). However, E2 as well as PPT prevented the depression in splenic dendritic cells, but not DPN, ER-β agonist, following trauma-hemorrhage (98). As observed for macrophages, the salutary effects of E2 on splenic dendritic cell functions are therefore mediated predominantly via ER-α (98).

Kupffer Cells

Kupffer cells, the largest population of tissue-fixed macrophages in the body, located in the liver sinusoids, produce increased amounts of IL-6, IL-10, and monocyte chemoattractant protein-1 (MCP-1) when exposed to and activated by pathogens, and contribute significantly to the systemic levels of these cytokines (99–101). Incidentally, studies in rodents have demonstrated that severe hypoxia, in the absence of blood loss or tissue trauma, produces a profound systemic inflammatory response and severe immunodepression, similar to that observed after trauma-hemorrhage—a condition associated with regional tissue hypoxia (99,100). It was observed that following trauma-hemorrhage there is a marked stimulation of IL-6 and TNF-α production by Kupffer cells (102). IL-10, an anti-inflammatory cytokine, peaked at 2 h after the insult. Kupffer cell depletion before trauma-hemorrhage reduced plasma IL-6, IL-10, and TNF-α levels, whereas treatment with anti–IL-10 after trauma-hemorrhage increased IL-6 and TNF-α levels (102–104). Activation of mitogen-activated protein kinases (MAPKs) is a potential mechanism for release of these inflammatory factors. In a murine model of hypoxia, it was found that hypoxia increases Kupffer cell IL-6 production by p38 MAPK activation via Src-dependent pathway (105,106). Src kinases are a family of nonreceptor protein tyrosine kinases (PTKs) that are expressed either ubiquitously or predominantly in specific immune competent cells. Animals treated with progesterone showed significantly reduced levels of the TNF-α, IL-6, and transaminases, as well as reduced myeloperoxidase activity in the liver. Further, in vitro treatment of Kupffer cells with progesterone decreased TNF-α synthesis (107). In a recent study, it was found that Kupffer cell TLR4, iNOS, IL-6, and TNF-α production capacities were increased; and ATP, Tfam, and mitochondrial cytochrome oxidase I (mtCOI) levels were decreased following trauma-hemorrhage, whereas E2 administration normalized these levels (108). Furthermore, the decreased Kupffer cell ATP and mtCOI levels were not observed in TLR4 mutant mice following trauma-hemorrhage, suggesting that downregulation of TLR4-dependent ATP production is critical to E2-mediated immunoprotection in Kupffer cells following trauma-hemorrhage (108). Activation of TLR4 initiates an inflammatory cascade involving activation of p38 MAPK, phosphatidylinositol 3-kinase (PI3K), and NF-κB, leading to the release of proinflammatory cytokines (109–111). Administration of E2 following trauma-hemorrhage in wild-type mice decreased Kupffer cell TLR4 expression, as well as prevented the phosphorylation of p38 MAPK and NF-κB, suggesting that the protective effect of estradiol on Kupffer cell function is mediated via downregulation of TLR4-dependent p38 MAPK and NF-κB signaling following trauma-hemorrhage—which prevents the systemic release of cytokines (109,110). Upon activation of TLR, MyD88, an adaptor protein that is shared by all TLR pathways, is recruited to TLR receptor domains and links TLR with the downstream intracellular signaling cascades (112,113). Hypoxia increased Kupffer cell TLR-4 expression in both males and proestrus females (114). However, expression of MyD88 and Src was down-regulated in Kupffer cells from proestrus females, whereas Src expression and phosphorylation were increased in Kupffer cells from males after hypoxia. So MyD88 likely plays the central role in IL-6 release in Kupffer cells from proestrus females, whereas Src is responsible for the production of IL-6 by Kupffer cells from males following hypoxia (114). A regulatory role of E2 on Kupffer cells is further confirmed by the presence of high-affinity E2 receptors on Kupffer cells and their significantly decreased expression after ovariectomy (115).

T Cells

Severe impairment in the functions of immune-competent cells has been observed following trauma and hemorrhage (4,116,117). The cytokines and chemokines released during trauma and hemorrhagic shock disrupt T-lymphocyte functions, and immune responses are suppressed in males, but not in proestrus females, after trauma-hemorrhage. When male C3H/HeN mice were castrated 2 weeks before the induction of soft-tissue trauma, splenocyte proliferation, splenocyte interleukin IL-2 and IL-3 release were significantly depressed in sham-castrated animals following trauma-hemorrhage, but not in precastrated males (118). Both androgen and estrogen receptors are present in T cells (119). Androgens, in particular, have been found to depress the release of the Th1 cytokine IL-2 by splenocytes following trauma-hemorrhage (87,89). In male animals, the enhanced release of the anti-inflammatory Th2 cytokine, IL-10, following trauma-hemorrhage also contributes to the depressed immune response under such conditions. Increased thymocyte apoptosis was also evident in males but not in proestrus females following trauma-hemorrhage (120). Angele et al. (121) demonstrated that male and female sex steroids differentially affect the release of Th1 and Th2 cytokines following trauma-hemorrhage. They observed a significant depression of splenocyte Th1 cytokines (IL-2 and IFN-γ) in DHT-treated castrated animals, DHT-treated females, and untreated males following trauma-hemorrhage, as opposed to maintained Th1 cytokine release in E2-treated males and females (121). The release of the anti-inflammatory cytokine IL-10 was markedly increased in DHT-treated mice and males subjected to trauma-hemorrhage compared with shams, but decreased in E2-treated mice and females, suggesting that male and female sex steroids differentially affect the release of Th1 and Th2 cytokines following trauma-hemorrhage (121).

Splenic T lymphocytes not only possess receptors for E2 but also contain enzymes involved in E2 metabolism. Analysis for aromatase and 17β-hydroxysteroid dehydrogenases indicated increased E2 synthesis and low conversion into estrone in T lymphocytes of proestrus but not of ovariectomized mice (122). It is suggested that the immunoprotection of proestrus females is associated with enhanced reductase function of the enzyme, whereas in males, decreased expression of oxidative isomer type IV, which impairs catabolism of DHT, probably augments immunosuppression (122). When T cells were stimulated in vitro in the presence of DHEA and a variety of hormone antagonists, the stimulatory effect of DHEA on splenocyte proliferation was unaltered by the testosterone receptor antagonist flutamide, whereas the E2 antagonist tamoxifen completely abrogated its effect (123). In addition, DHEA administration normalized the elevated serum corticosterone level typically seen following injury, indicating that DHEA improves splenocyte function after trauma-hemorrhage by directly stimulating T cells, and also by preventing a rise in serum corticosterone (123). The activity of 26s proteasome from CD3⁺CD4⁺ and CD3⁺CD8⁺ splenic T lymphocytes was enhanced following trauma-hemorrhage, which was associated with increased expression of NF-κB and STAT1 (124). PPT, but not DPN, administration following trauma-hemorrhage was as effective as E2 in preventing T-cell suppression (87,125). So it appears that ER-α plays a predominant role in mediating the salutary effects of 17β-estradiol on T cells following trauma-hemorrhage, and that such effects are likely mediated via normalization of MAPK, NF-κB, and AP-1 signaling pathways (125).

Alterations in B-cell repertoire have also been studied following hemorrhage. When no changes in the total number of splenocytes or of splenic B cells were found after hemorrhage, decreases of >40% in the total number of Ig-producing cells—as well as in the numbers of B cells secreting IgM, IgA, and IgG2b—were found during the period of 2 to 96 h posthemorrhage (126).

According to Abraham and colleagues (127,128), hemorrhage produces marked alterations in pulmonary and intestinal B cell repertoires, which are suggested to contribute to postinjury abnormalities in host defenses.

CONCLUSION

Animal models clearly demonstrate a sex-dependent immune response following trauma-hemorrhage. Some of the contradicting reports in humans might be due to unknown hormonal status, preexisting disease conditions, varying nutritional status, and genetic heterogeneity of the patients. There is marked immune suppression within the first hour following trauma-hemorrhage in experimental animals, and the prolonged immune suppression leads to sepsis and multiorgan failure. As discussed above, specific immunological components such as antigen-presenting cells, T cells, and Kupffer cells are significantly affected by trauma-hemorrhage. The sex hormones, androgens, and estrogens play a major role in the immune alteration seen in the animal model, and the adverse effects can be largely restored by E2 administration. Estrogen, therefore, appears to be a useful therapeutic adjunct for the treatment of trauma-hemorrhage complications, and consequently for preventing the subsequent septic complications and mortality rates under those conditions.